Done SJ - Search Results

1

Embryonic protein nodal promotes breast cancer vascularization.

Quail DF, Walsh LA, Zhang G, Findlay SD, Moreno J, Fung L, Ablack A, Lewis JD, Done SJ, Hess DA, Postovit LM. Quail DF, et al. Among authors: done sj. Cancer Res. 2012 Aug 1;72(15):3851-63. doi: 10.1158/0008-5472.CAN-11-3951. Cancer Res. 2012. PMID: 22855743

2

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL. Done SJ, et al. Cancer Res. 1998 Feb 15;58(4):785-9. Cancer Res. 1998. PMID: 9485035

3

P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers.

Done SJ, Arneson CR, Ozçelik H, Redston M, Andrulis IL. Done SJ, et al. Breast Cancer Res Treat. 2001 Jan;65(2):111-8. doi: 10.1023/a:1006425809069. Breast Cancer Res Treat. 2001. PMID: 11261826

4

Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.

Cheung AM, Elia A, Tsao MS, Done S, Wagner KU, Hennighausen L, Hakem R, Mak TW. Cheung AM, et al. Cancer Res. 2004 Mar 15;64(6):1959-65. doi: 10.1158/0008-5472.can-03-2270. Cancer Res. 2004. PMID: 15026330

5

LAF-4 is aberrantly expressed in human breast cancer.

To MD, Faseruk SA, Gokgoz N, Pinnaduwage D, Done SJ, Andrulis IL. To MD, et al. Among authors: done sj. Int J Cancer. 2005 Jul 1;115(4):568-74. doi: 10.1002/ijc.20881. Int J Cancer. 2005. PMID: 15704140

6

Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.

Cully M, Shiu J, Piekorz RP, Muller WJ, Done SJ, Mak TW. Cully M, et al. Among authors: done sj. Cancer Res. 2005 Nov 15;65(22):10363-70. doi: 10.1158/0008-5472.CAN-05-1633. Cancer Res. 2005. PMID: 16288026

7

Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasion.

Wang C, Navab R, Iakovlev V, Leng Y, Zhang J, Tsao MS, Siminovitch K, McCready DR, Done SJ. Wang C, et al. Among authors: done sj. Mol Cancer Res. 2007 Oct;5(10):1031-9. doi: 10.1158/1541-7786.MCR-06-0391. Mol Cancer Res. 2007. PMID: 17951403

8

Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.

Iakovlev VV, Arneson NC, Wong V, Wang C, Leung S, Iakovleva G, Warren K, Pintilie M, Done SJ. Iakovlev VV, et al. Among authors: done sj. Clin Cancer Res. 2008 Jul 15;14(14):4446-54. doi: 10.1158/1078-0432.CCR-07-4960. Clin Cancer Res. 2008. PMID: 18628458

9

Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model.

Tran-Thanh D, Buttars S, Wen Y, Wilson C, Done SJ. Tran-Thanh D, et al. Among authors: done sj. Cancer Prev Res (Phila). 2010 Feb;3(2):202-11. doi: 10.1158/1940-6207.CAPR-09-0181. Epub 2010 Jan 26. Cancer Prev Res (Phila). 2010. PMID: 20103725

10

Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation.

Wang C, Tran-Thanh D, Moreno JC, Cawthorn TR, Jacks LM, Wang DY, McCready DR, Done SJ. Wang C, et al. Among authors: done sj. Breast Cancer Res Treat. 2011 Sep;129(2):373-86. doi: 10.1007/s10549-010-1241-0. Epub 2010 Nov 3. Breast Cancer Res Treat. 2011. PMID: 21046228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters